4.7 Article

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)

Related references

Note: Only part of the references are listed.
Article Ophthalmology

EFFICACY OF 1.25 MG VERSUS 2.5 MG INTRAVITREAL BEVACIZUMAB FOR DIABETIC MACULAR EDEMA Six-Month Results of a Randomized Controlled Trial

Dennis S. C. Lam et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)

Article Medicine, General & Internal

Ranibizumab for neovascular age-related macular degeneration

Philip J. Rosenfeld et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Ranibizumab versus verteporfin for neovascular age-related macular degeneration

David M. Brown et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Ophthalmology

Cataract progression after intravitreal triamcinolone injection

O Çekiç et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)

Article Ophthalmology

A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema

D Thomas et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2005)